Larotrectinib

About

Therapy type: Targeted therapy

Therapy strategy: NTRK inhibition

Mappings

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Organization(s) Biomarker(s) Cancer type Therapy(ies)
EMA (1) FDA (1) v::NTRK1 Any solid tumor Larotrectinib
EMA (1) FDA (1) v::NTRK2 Any solid tumor Larotrectinib
EMA (1) FDA (1) v::NTRK3 Any solid tumor Larotrectinib